Bioxyne Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
2,305.20
1,492.10
1,924.50
1,786.70
1,991.80
Cost of Goods Sold (COGS) incl. D&A
1,418.50
879.60
1,029.20
806.90
1,428.40
Gross Income
886.70
612.50
895.30
979.70
563.40
SG&A Expense
706.40
571.20
769.70
1,688.60
2,143.40
EBIT
180.30
41.30
125.50
708.90
1,580.10
Unusual Expense
-
-
-
325.00
-
Non Operating Income/Expense
1,004.80
151.70
43.90
43.10
85.70
Pretax Income
1,190.80
201.00
170.60
990.20
1,456.40
Income Tax
-
-
53.30
224.50
144.50
Consolidated Net Income
1,190.80
201.00
223.80
765.80
1,311.80
Net Income
1,190.80
201.00
223.80
765.80
1,311.80
Net Income After Extraordinaries
1,190.80
201.00
223.80
765.80
1,311.80
Net Income Available to Common
1,190.80
201.00
223.80
765.80
1,311.80
EPS (Basic)
0.01
0.00
0.00
0.00
0.00
Basic Shares Outstanding
260,451.30
286,204.40
286,659.80
236,155.00
587,804.50
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
260,451.30
286,204.40
286,773.60
236,155.00
587,804.50
EBITDA
180.70
41.30
125.50
707.90
1,566.50
Non-Operating Interest Income
5.70
8.00
1.10
0.50
38.00
About Bioxyne
View Profile
